Table 1 Patient characteristics and echocardiographic measurements in low-flow (SVI < 35 ml/m2) versus normal-flow (SVI ≥ 35 ml/m2) severe AS (AVA ≤ 0.1) with preserved LVEF (>50%).
Variables | Low-flow (n = 121) | Normal-flow (n = 231) | Mean Difference/Odds Ratio (95% Confidence Interval) | p-value |
---|---|---|---|---|
Age | 73.5 (±13.8) | 69.9 (±13.5) | 3.6 (0.6–6.6) | 0.020 |
Height (cm) | 164.6 (±19.7) | 156.0 (±17.2) | 8.6 (−3.7–20.8) | 0.169 |
Weight (kg) | 60.5 (±12.4) | 58.8 (±13.3) | 1.6 (−1.2–4.5) | 0.268 |
BSA (m2) | 1.63 (±0.29) | 1.59 (±0.25) | 0.03 (−0.01–0.10) | 0.136 |
Hypertension | 68.5% | 61.9% | 1.34 (0.791–1.32) | 0.275 |
Diabetes mellitus | 47.8% | 35.6% | 1.66 (1.01–2.75) | 0.047 |
Hyperlipidaemia | 55.4% | 41.8% | 1.74 (1.05–2.86) | 0.030 |
Atrial fibrillation | 11.9% | 7.2% | 1.41 (0.634–3.16) | 0.396 |
Ischaemic heart disease | 34.8% | 28.4% | 1.34 (0.793–2.29) | 0.269 |
Chronic kidney disease | 20.6% | 10.8% | 2.14 (1.08–4.22) | 0.025 |
Echocardiographic measurement | ||||
Left ventricular ejection fraction (%) | 65.2 (±7.5) | 66.5 (±7.2) | −1.3 (−2.9–0.3) | 0.116 |
End-diastolic volume (ml) | 70.8 (±17.7) | 113.0 (±26.0) | −42.2 (−47.4 – −37.6) | <0.001 |
Stroke volume index (ml/m2) | 28.3 (±5.9) | 46.7 (±9.5) | −18.3 (−20.2–16.4) | <0.001 |
Left ventricular mass index (g/m2) | 100.3 (±31.4) | 129.8 (±36.2) | −29.5 (−37.3 – −21.7) | <0.001 |
End-systolic wall stress (x 103 dyn/cm2) | 65.0 (±28.3) | 76.3 (±36.2) | −11.3 (−23.0–0.4) | 0.058 |
Aortic valve indices | ||||
Aortic valve area (cm2) | 0.77 (±0.17) | 0.78 (±0.17) | −0.01 (−0.05–0.03) | 0.633 |
Transaortic mean pressure gradient (mmHg) | 34.1 (±19.8) | 36.7 (±20.3) | −2.6 (−7.0–1.9) | 0.260 |
Transaortic peak velocity (cm/s) | 367.5 (±94.6) | 383.2 (±96.2) | −15.7 (−36.9–5.4) | 0.144 |
LV diastolic function | ||||
E (cm/s) | 83.8 (±31.5) | 89.4 (±30.7) | −5.7 (−12.5–1.2) | 0.104 |
A (cm/s) | 89.9 (±42.1) | 89.7 (±38.6) | 0.2 (−8.6–9.0) | 0.965 |
E/A ratio | 2.03 (±1.01) | 0.94 (±0.77) | 1.1 (−0.8–3.0) | 0.264 |
Deceleration time (ms) | 203.1 (±91.4) | 211.0 (±83.7) | −7.9 (−27.0–11.2) | 0.415 |
Septal e’ | 5.39 (±3.65) | 5.02 (±3.64) | 0.37 (−0.44–1.17) | 0.371 |
Septal E/e’ | 13.3 (±8.5) | 12.4 (±9.2) | 0.87 (−1.21–2.95) | 0.411 |
Lateral e’ | 6.27 (±3.90) | 5.70 (4.00) | 0.57 (−0.31–1.44) | 0.204 |
Lateral E/e’ | 10.73 (±6.12) | 10.53 (±7.32) | 0.20 (−1.43–1.83) | 0.809 |
LV systolic function | ||||
Septal S’ (cm/s) | 5.50 (±3.27) | 4.98 (±3.42) | 0.52 (−0.22–1.27) | 0.166 |
Lateral S’ (cm/s) | 6.51 (±3.90) | 5.86 (±3.86) | 0.65 (−0.20–1.51) | 0.133 |
Prognostic markers in AS | ||||
Stroke work loss (%) | 25.7 (±16.2) | 28.1 (±18.0) | −2.4 (−6.2–1.5) | 0.223 |
Systemic arterial compliance (ACU) | 0.49 (±0.20) | 0.81 (±0.36) | −0.32 (−0.39–0.26) | <0.001 |
Global LV contractility index, dσ*/dtmax | 2.73 (±1.27) | 2.41 (±1.00) | 0.31 (−0.08–0.72) | 0.117 |
Aortic valve resistance (dyn s /cm2) | 198.7 (±155.0) | 190.7 (±162.5) | 8.0 (−27.3–43.3) | 0.656 |
Valvuloarterial impedance (mmHg/ml/m2) | 5.48 (±4.36) | 3.04 (±0.79) | 2.44 (1.86–3.02) | <0.001 |
LV Stiffness Index | ||||
Lateral E:e’/EDV (ml-1) | 0.165 (±0.130) | 0.098 (±0.072) | 0.066 (0.044–0.089) | <0.001 |